A Randomized, Controlled, Phase 1/2 Trial of a Neisseria meningitidis Serogroup B Bivalent rLP2086 Vaccine in Healthy Children and Adolescents

出版年份 2012 全文链接

标题

作者

关键词

出版物

Volume 32, Issue 4, Pages 364-371

出版商

Ovid Technologies (Wolters Kluwer Health)

发表日期

2012-10-31

DOI

10.1097/inf.0b013e31827b0d24

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discuss science. Find collaborators. Network.

Join a conversation